European Medicines Agency Human Scientific Committees' Working Party with Patients' and Consumers' Organisations (PCWP) plenary meeting with all eligible organisations

• Date:
  Keskiviikko, 30 marraskuu 2011, Koko päivä
• Paikka:
  European Medicines Agency, Amsterdam, the Netherlands

Day 2: This meeting includes an introduction from the new Executive Director. Some of the general issues for discsussion at the meeting are the implementation of the anti-falsification legislation; additional monitoring of medicines and direct patient reporting; legislation on information to patients; results of survey project on representativeness in Agency stakeholder groups; outcome of the scientific advisory group pilot phase; and process for re-evaluation of eligibility.Registration by invitation only.

Documents

Agenda - European Medicines Agency Human Scientific Committees' Working Party with Patients' and Consumers' Organisations (PCWP) meeting with all eligible organisations

Reference Number: EMA/545915/2011

Minutes of the European Medicines Agency Human Scientific Committees' Working Party with Patients' and Consumers' Organisations (PCWP) with all eligible organisations

Adopted Reference Number: EMA/545922/2011

Presentation - Implementation of the road map to 2015; implications for patients/consumers

Presentation - Implementation of falsified medicines Directive

Presentation - New pharmacovigilance legislation: Update on implementation

Presentation - Additional monitoring of medicines and direct patient reporting – impact on the package leaflet

Presentation - Information to patients

Presentation - Streamlined procedure for evaluation of eligibility criteria of patients' and consumers' organisations

Presentation - European Medicines Agency Human Scientific Committees' Working Party with Patients' and Consumers' Organisations workplan 2012